Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 4,047
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
for
Arrhythmogenic Right Ventricular Cardiomyopathy
Location: New York NY, Boston MA, Baltimore MD, Cleveland OH,
Sponsor: Tenaya Therapeutics
Sex: All
Age: 14 - 65
Code: NCT06311708
Recruiting
Safe Mothers, Safe Children Initiative
for
PTSD, Depression, Child Maltreatment
Location: New York NY
Sponsor: New York University
Sex: All
Age: 18+
Code: NCT04752618
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
for
Overactive Bladder, Urinary Urgency Incontinence,
Location: New York NY, Bala-Cynwyd PA, Annapolis MD,
Sponsor: Axonics, Inc.
Sex: Male
Age: 18+
Code: NCT06511141
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for
Primary Generalized Tonic-Clonic Seizures
Location: Hackensack NJ, Philadelphia PA, Baltimore MD,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 12+
Code: NCT05667142
Phase 3, Recruiting
An Evidence-based Approach for Bullying Prevention
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
for
Functional Mitral Regurgitation, Heart Failure,
Location: Edison NJ, Newark NJ, New York NY, Poughkeepsie NY,
Sponsor: Cardiac Dimensions, Inc.
Sex: All
Age: 18+
Code: NCT03142152
Recruiting
Neural Biomarkers of Electroconvulsive Therapy Response
for
Electroconvulsive Therapy Treated Patients
Location: Glen Oaks NY
Sponsor: Northwell Health
Sex: All
Age: 18 - 70+
Code: NCT04763655
Recruiting
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
for
Hemophilia A
Location: New Hyde Park NY, Little Rock AR
Sponsor: Green Cross Corporation
Sex: All
Age: 0+
Code: NCT02027779
Phase 3, Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants